ABSTRACT
S
ome HPSs and most FDs used to treat intracranial aneurysms are constructed with multiple braided metal filaments to allow compression and loading into a microcatheter lumen. Once deployed into vascular structures of a larger diameter, these expand and shorten as they return toward their original size and conformation. We have previously shown in animal models that as these devices adapt to the constraints of local anatomy, the ensuing deformations can lead to substantial variations in device porosity between cases treated with the same device as well as wide variations in porosity along the different segments of the same device. 1, 2 Ideally, the aim of a flow-diversion treatment strategy is to form a tubular conduit of optimal porosity that will normalize linear flow, reconstruct the parent vessel, and effectively occlude the aneurysm while preserving arterial branches and perforators. Because the amount of "metallic coverage" of aneurysm and branch ostia may affect treatment safety and efficacy, it is desirable to accurately predict when and to what extent these deformations will occur and how these will influence device porosity. We have previously tested both high-porosity braided selfexpanding stents and flow diverters in wide-neck, bifurcation, and giant aneurysm models, and failures have occurred, particularly when devices were deployed in a curved configuration. [1] [2] [3] Device deformations and subsequent heterogeneity in device porosity were frequent and sometimes quite substantial. [1] [2] [3] When in vivo porosities of the portion of the devices bridging the aneurysm ostium were measured, it became clear that these were strongly influenced by the discrepancy in diameter between the parent artery and the portion of the device that was free to expand at the level of the aneurysm neck. This phenomenon could perhaps explain some failures of flow diversion and the lack of neointima formation at the neck of treated aneurysms, with persisting aneurysm filling despite FD treatment. 2, 3 In vitro studies that have hitherto been published have failed to uncover these variations because they studied stents and FDs in closed tubes. 4 We here present the results of several simple experiments that permit a better understanding and more accurate prediction of the changes in structure of braided self-expanding stents and FDs as these adapt to the common types of geometric constraints encountered in treating aneurysms. This work can help inform the proper choice of stent and length of landing zone, and perhaps also illuminate some technical aspects of an intervention, in terms of the utility of the practice of intentional device compaction across the aneurysm neck.
MATERIALS AND METHODS

Materials
The main characteristics of studied stents and FDs are summarized in Table  and illustrated in Fig 1. These included 5 devices: 1 HPS, 1 low-porosity FD (FD 48 ) similar to commercially available devices, and 3 prototype braided stent-in-stent endoluminal flow-diverting devices, composed of an outer HPS and an inner FD mesh of lower porosity and higher pore density, made with either 36, 48, or 64 wires, all gifts from MicroVention (Aliso Viejo, California). Experiments were performed with silicone tubes of various diameters (2, 2.5, and 3 mm), to simulate intracranial parent arteries and branches. Scaled microphotographs were taken for each experimental step with a stereo microscope and analyzed with image processing software (ImageJ; National Institutes of Health, Bethesda, Maryland).
Methods
In each experimental setup, the stent or FD was submitted to constraining conditions but also allowed to "react" to those conditions. The device extremities were 1) constrained within tubes of various diameters (simulating the parent artery or a branch of a bifurcation), and forced to follow geometries (curves of decreasing radii of curvature for example) or compacted by axial approximation of the tubes but 2) the device midsection was free to expand or adapt between constrained extremities (simulating the room made available at the level of a bifurcation and/or the neck of the aneurysm) (Fig 1) . The pattern of strut distribution after each deformation was used to differentiate 3 different zones, which will be described. In each zone, parameters that were recorded included SF, defined as the number of struts per unit length, porosity (P), defined as the proportion of the surface area without metal coverage over total surface area, and pore density, the number of metal-enclosed pores per unit surface area. The effect of tube size was analyzed for each set of experiments. SF at different degrees of axial compression was determined by selecting a given stent segment and counting the number of struts per unit of length; and P was determined by measuring (1 Ϫ Total Metal Surface Area) ϫ 100%. For a given device, there is a direct relationship between P, SF, and pore attenuation. P will be used as the variable for most reported results. The experiments can be divided into 3 sets: 1) The first set was designed to test the impact of axial compression (0 -7 mm) on strut distribution within the portion of the device free to react to such manipulations, the free segment of stent (or FSS). The experiments were repeated with extremities of the device inserted in tubes of 2, 2.5, and 3 mm in diameter. The hypothesis was that, because the surface of a cylinder can be estimated by the formula: 2rl (where r and l are the radius and length of the cylinder), any decrease in the length available for metallic deployment, in the absence of a change in radius (changes do not occur in the midportion of the stent; see below), would automatically result in a proportional increase in SF or metallic attenuation and a decrease in porosity according to the formula: SF 2 /SF 1 ϭ l 1 /l 2 ϭ 1 Ϫ P 2 /1 Ϫ P 1 . This relationship was verified empirically.
2) The second set of experiments evaluated the effects of curvatures on porosity. Devices deployed into silicone tubes of various diameters at each extremity were bent to 0, 45, 90, and 135°. For each curvature, stents and FDs were also shortened bilaterally by 0 -2 mm to measure the impact of axial compression combined with curvature on parameters of interest. The stent strut distribution was compared between the convex and the concave surfaces of the FSS and at the level of various stent and FD zones. The hypothesis was that as the device follows the curve, the length available for the distribution of metal struts would differ between the convex and concave side of the curvature, with P and SF varying according to the ratio of the arc of the convex surface (Cv) over the arc of the concave surface (Cc):
The strength of the correlations between dependent variables (eg, distance between tubes, arc ratios) and resulting porosities were estimated by using the Pearson correlation coefficient R 2 .
3) The final set of experiments was designed to assess the behavior of the terminal ends of the device within the various sizes of silicone tubes, to simulate landing zones. The length of the landing zone was sequentially decreased, and the diameter of the terminal end of the device was measured. Various devices (HPS, FDs, stent-in-stent endoluminal flow-diverting devices with 48 or 64 wires) were deployed into silicone tubes of 2-, 2.5-, and 3-mm diameters. Experiments were repeated in glass tubes of the same diameter. Overall, 370 experiments were performed. 
RESULTS
Zones
Placement of both ends of all devices into the tubes led to a redistribution of the struts according to 3 distinct zones, shown in Figs 1 and 2 . The constrained or landing Zone 1 is the portion still inside the silicone tube; the unconstrained segment of the stent or FD, the FSS, can be further divided into 2 transition Zone 2 , beginning immediately as the stent exits the tube, on both sides, and a middle expansion Zone 3 , where the device has been allowed to expand completely, found between each transition Zone 2 (Fig 3, A-D) . Both the inner and the outer stents of the stent-in-stent endoluminal flow-diverting devices displayed the same pattern (Fig 1, E-H ).
Landing Zone 1
Constraining the device in tubes of progressively smaller diameter led to a small but linear decrease in porosity within the landing Zone 1 (for example, from 90% to 87 Ϯ 2% for the HPS). Application of axial compression, bending, or combined axial compression with bending did not change the strut frequency or porosity of the device within this Zone 1 (Fig 2B, -D) .
Transition Zone 2
The free segment of stent is composed of 2 transitions Zone 2 and 1 compaction Zone 3 . The transition Zone 2 exists because of the difference in diameters between landing Zone 1 (constrained within the tube) and Zone 3 (free to expand). The transition Zone 2 is absent if the device has the same or smaller diameter than the tube (or parent vessel). With tubes of decreasing diameter, or with progressive relative oversizing of the device, the transition Zone 2 becomes longer (Pearson R 2 ϭ 0.99) and an increasing proportion of the FSS is occupied by the more porous transition Zone 2 (Fig 3) . In all cases, the porosity follows a gradient, progressive and continuous along Zone 2 , between the maximum values found within the tube (Zone 1 ) and the minimal values found at Zone 3 . Axial compression and progressive curving had minimal effect on the porosity of the transition Zone 2 (Figs 2-4) .
Expansion Zone 3
The expansion Zone 3 is the only segment of the FSS that responds to compaction and angulation of the device. The 2 extremities of Zone 3 consisted of 2 areas that appeared to be more dense in metallic coverage than the middle of Zone 3 (Figs 1 and 3 ). For simplicity, and because this distinction disappeared with increasing compaction, these will not be considered as individual entities. In contrast to the transition Zone 2 , this portion of the stent underwent a significant decrease in porosity with approximation of the tubes. In keeping with our hypothesis, this fol- lows a linear correlation with Pearson R 2 values of 0.93 or greater for all devices. With axial compression of 0 -7 mm, the HPS porosity went from 80% to 72% and, for FDs, from 53% to 0% (Fig 2, B-D) .
Bending the device from 0 to 135°i ncreased porosity on the convex surface of the compaction Zone 3 , while decreasing porosity on the concave surface (Fig 5) . The change in porosity was directly proportional to the arc ratios, as hypothesized, with Pearson R 2 values of 0.95 for the HPS. Axial compression of the curved device, regardless of the degree of curvature, had the effect of "compacting" or increasing SF, thus decreasing the porosity of both the convex and the concave surfaces, but only within the compaction Zone 3 ; the transition Zone 2 and landing Zone 1 remained unchanged (Figs 4 and 5 ).
Minimal Length of the Landing Zone 1
With all FD devices deployed into silicone tubes, some degree of stenosis at the terminal ends could be observed. No such phenomenon was noted with the HPS or when we deployed devices into glass tubes. The stenosis increased from a minimal (4%) to severe (60%) stenosis as the length of the landing Zone 1 was progressively decreased, as shown in Fig 6. The stenosis-producing phenomenon became more pronounced with more marked mismatch between the diameter of the FDs and that of the constraining tubes. The stenosis at the ends of the device was more pronounced with devices of lesser nominal porosity. When a short landing zone was combined with a substantial angulation, the stenosis was asymmetrical (Fig 6) .
DISCUSSION
The salient findings of this study are as follows:
1) Braided stents and FDs can exhibit major heterogeneities in porosity as these are subjected to various experimental conditions, including being simultaneously constrained into vessels of a smaller diameter than their nominal diameter but free to expand between the 2 constrained extremities.
2) The device adapts according to 3 characteristic zones.
3) It is possible to compact stents and FDs and to a certain extent decrease porosities in hope of increasing efficacy of the stenting or FD strategy, but this works only at the level of the compaction Zone 3 ; a limiting factor is the transition Zone 2 , of relatively higher porosity, which remains relatively unchanged. 4) Changes in porosity due either to deployment techniques such as compaction or anatomic factors such as curvatures are predictable once it is recognized that changes are limited to the compaction Zone 3 ; these predictable alterations follow relatively simple geometric rules. 5) Stenoses at the level of the stent extremities can occur if the landing zone is too short. We have tested high porosity braided stents and flow diverters in wide-neck, bifurcation, and giant aneurysm models, and failures have occurred, particularly when the device was deployed in a curved configuration. [1] [2] [3] When in vivo porosities of the segments of devices bridging the aneurysm ostium were measured, it became clear that these were strongly influenced by discrepancies in diameters between the parent artery and the segment free to expand at the level of the aneurysm neck or bifurcation. Device deformations and subsequent heterogeneity in device porosity were frequent and sometimes severe. [1] [2] [3] The invariably increased porosity at the transition Zone 2 may perhaps explain some failures of flow diversion, along with a lack of neointima formation across the neck of treated aneurysms and persistent filling after treatment. 1, 2, 5 The benchtop experiments presented here were designed to model in vivo findings we encountered after experimentation in a canine aneurysm model, as shown in Fig 7. Many of our observations were most obvious when there was a significant discrepancy between stent size and vessel lumen. Previous in vitro studies have emphasized the importance of matching the size of the device with the diameter of the parent artery, 4 and to this we are adding that device oversizing may also increase the length of the transition zone, a segment of device whose porosity is greater than the expansion zone. It is noteworthy that unlike the compaction zone, the porosity of the transition Zone 2 cannot be decreased with technical maneuvers such as axial compression.
The problems with device deployment into curved configurations have previously been studied, with an emphasis on changes in flow patterns, the angle progressively converting shear-driven into inertia-driven flows. 6, 7 The increased porosities on the convexity of an acute curve may also decrease the efficacy of a FD strategy. 2, 4 This has recently been shown in computational fluid dynamics models. 7 Although the bench experiments can show the changing porosity of the device, the reality of deploying flow diverters within a curve is more complex. Transmitting force around a corner to get the device to open can cause problems when treating patients with FDs. Prior understanding of patientspecific blood vessel and aneurysm anatomy, along with required degree of curvature of the deployed endovascular device, would be important elements to consider when attempting to prescribe an amount of metallic coverage over an aneurysm or important branch ostium. Industry partners should develop charts or graphs of resultant device porosities, at each device diameter, depending on parent vessel diameter, and approximate curvature, to facilitate the prescriptive process.
Because the problems we describe here have now been repro- duced with all devices we have tested, these seem to be intrinsic to their braided self-expandable nature. Ways to circumvent or palliate the problems can be imagined: intra-aneurysmal coils may prevent some expansion of the device at the level of the neck, or telescoping stents or flow diverters of progressively smaller diameters may decrease the discrepancies and minimize the phenomenon. These techniques should first be attempted in preclinical studies, because they may potentially increase other types of complications, such as parent vessel thrombosis. Device stenosis occurring at the terminal ends of a device has been documented in some animal models, particularly when the device undergoes substantial expansion into the aneurysm neck (where a more marked discrepancy exists between diameters at the aneurysm ostium and the parent artery), with short landing zones (Fig 6) . The present study suggests that this phenomenon may be prevented by choosing a long enough device to leave adequately long landing zones on either side of the aneurysm neck. Device manufacturers could also provide data on anticipated degree of device stenosis at each length of landing zone.
Limitations
Many devices used for this study were prototypes, and results may not apply to clinically available FDs. Recently, the HPS has been approved in Europe and Canada (LVIS; MicroVention). The FD 48 construction was modeled on the Pipeline device (ev3, Irvine, California). In vitro experiments were done in artificial environments, and although many phenomena have been documented in experimental animals, it is unclear whether and to what degree the same problems occur with currently approved intravascular devices in clinical applications. In vivo conditions may differ significantly from our experimental conditions, and any inference to human applications must be cautious.
CONCLUSIONS
Braided stents and FDs may exhibit heterogeneities in porosity that are to a certain extent predictable. Carefully matching device and parent vessel diameters and providing sufficient landing zones may prevent deformations that could affect the clinical results of stent placement and flow diversion in the treatment of complex aneurysms. 
